Lancet. 2009 Oct 10;374(9697):1226. doi: 10.1016/S0140-6736(09)61768-2.

Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

[No authors listed]

Retraction of

Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Lancet. 2003 Jan 11;361(9352):117-24.

PMID:: 19819378; [PubMed - indexed for MEDLINE]

Publication Types

Retraction of Publication

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Retraction. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. [Ann Intern Med. 2009]
Retraction. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
[No authors listed]Ann Intern Med. 2009 Dec 15; 151(12):897.
Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD? [Am J Kidney Dis. 2009]
Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD?
Berns JS. Am J Kidney Dis. 2009 Feb; 53(2):192-6.
Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects. [ACP J Club. 2008]
Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects.
Granger CB. ACP J Club. 2008 Mar-Apr; 148(2):35.
Review [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases]. [Lakartidningen. 2009]
Review [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
Alhadad A, Sterner G, Herlitz H. Lakartidningen. 2009 Oct 28-Nov 3; 106(44):2836-8, 2840.
Review Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. [South Med J. 2009]
Review Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
Basile J, Toth PP. South Med J. 2009 Oct; 102(10 Suppl):S1-S12.

See reviews... See all...

Cited by 5 PubMed Central articles

Review Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. [BMJ. 2013]
Review Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.
Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. BMJ. 2013 Jan 28; 346:f360. Epub 2013 Jan 28.
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. [BMJ. 2011]
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD, HOlland NEphrology STudy Group. BMJ. 2011 Jul 26; 343:d4366. Epub 2011 Jul 26.
Review Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease. [Curr Diab Rep. 2010]
Review Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.
Pichler RH, de Boer IH. Curr Diab Rep. 2010 Aug; 10(4):297-305.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Retraction--Combination treatment of angiotensin-II receptor blocker and angiote...
Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
Lancet. 2009 Oct 10 ;374(9697):1226. doi: 10.1016/S0140-6736(09)61768-2.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

Retraction of

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 5 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information